Abstract
Objective: To develop and evaluate the psychometric properties (reliability, validity etc.) of a comprehensive Quality of Life (QOL) tool, for patients infected with the human immunodeficiency virus (HIV), that was adapted from a previously validated cancer tool. Design: Cross-sectional, patient completed written surveys and interviews. Setting: The Medical Centers serving HIV infected patients in the Los Angeles community including UCLA, community physicians, Veterans Affairs Medical Centers, and a County hospital: and additional data contributed from Johns Hopkins University Medical Center CMV Retinitis Clinic. Patients: Patients (n=318) with HIV infection including asymptomatic (37%), ARC (20%), AIDS (25%) and AIDS with Cancer (18%) receiving health services at one of the above sites. Measurements: The patients self-administered the newly developed instrument, the HOPES (HIVOverview ofProblems-EvaluationSystem), other QOL related tools including the Medical Outcomes Study instrument adapted for HIV (MOS-HIV) the Profile of Mood States (POMS), the Perceived Adjustment to Chronic Illness Scale (PACIS), and the Physical Activity Scale (PAS). Brief interview to assess the Karnofsky Performance Status Score (KPS). Measured sociodemographic characteristics included age, sex, race, HIV risk factor, education etc. Assessed medical history, current medications, HIV clinical classification. Main results: The sociodemographic and medical characteristics of the sample resemble those of the general population with HIV infection in this geographic area: 96% male, 28% nonwhite, 84% homosexual contact as risk factor, 75% receiving antiretroviral therapy. The adaptation of the cancer QOL instrument to HIV appears to have face and content validity according to patients and health professionals who care for HIV infected patients. Analyses of the psychometric properties found that the HOPES has a similar structure to its parent instrument following factor analyses which results in five summary scales representing the Physical, Psychosocial, Medical Interaction, Sexual and Significant Other/Partners domains in addition to a Global Score. Internal consistency of 35 subscales is high with a mean alpha coefficient of 0.82. Correlations of the HOPES summary scales with other QOL instruments are in the predicted directions. Comparing patients within the HIV clinical diagnostic categories on the HOPES Global, Physical, and Psychosocial Summary Scales indicates that Asymptomatic Patients have better QOL than symptomatic patients. This finding is also found in the other QOL instruments which provides evidence of construct validity. Conclusions: The HOPES is an excellent tool for identifying the problems and needs of patients with HIV infection and for assessing their quality of life. It is reliable, valid and acceptable to patients. The tool may be especially useful in developing a normative data base.
Similar content being viewed by others
References
FischlMA, RichmanDD, GriecoMH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex.N Engl J Med 1987;317: 185–191.
LambertJS, SeidlinM, ReichmanRC, et al. 2′,3′-dideoxyinosine (ddi) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A Phase I trial.N Engl J Med 1990;322: 1333–1340.
GrahamNMJ, ZegerSL, ParkLP, et al. The effects of survival of early treatment of human immunodeficiency virus infection.N Engl J Med 1992;326: 1037–1042.
WuAW, MathewsWC, BryskLT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.J Acquir Immune Defic Synd 1990;3: 683–690.
RagsdaleD, MorrowJR. Quality of life as a function of HIV classification.Nurs Res 1990;39: 355–359.
LongoMB, SprossJA, LockeAM. Identifying major concerns of persons with acquired immunodeficiency syndrome: a replication.Clin Nurse Specialist 1990;4(1): 21–22.
FawzyIF, NamirS, WolcottDL, MitsuyasuRT, GottliebMS. The relationship between medical and psychological status in newly diagnosed gay men with AIDS.Psychiatric Med 1989;7: 23–33.
JohnsonJP, McCauleyCR, CopleyJB. The quality of life of hemodialysis and transplant patients.Kidney International 1982;22: 286–291.
McSweenyAJ, GrantI, HeatonRK, AdamsKM, TimmsRM. Life quality of patients with chronic obstructive pulmonary disease.Arch Inter Med 1982;142: 473–478.
CellaDF, TulskyDS. Measuring quality of life today: methodological aspects.Oncology 1990;4: 29–38.
MorrisJN, SherwoodS. Quality of life of cancer patients at different stages in the disease trajectory.J Chronic Dis 1987;40: 545–553.
PadillaG, GrantM. Quality of life as a cancer nursing outcome variable.Adv Nurs Sci 1985;10: 45–60.
GanzPA, SchagCAC, ChengH. Assessing the quality of life in newly-diagnosed breast cancer patients.J Clin Epid 1990;43: 75–86.
AaronsonNK. Quality of life: What is it? How should it be measured?Oncology 1988;2: 69–74.
SchipperH, LevittM. Measuring quality of life: Risks and benefits.Cancer Treat Rep 1985;69: 1115–1123.
WareJEJr. Conceptualizing disease impact and treatment outcomes.Cancer 1984;53 (suppl): 2316.
DonovanK, Sanson-FisherRW, RedmanS. Measuring quality of life in cancer patients.J Clin Oncol 1989;7: 959–968.
MoinpourCM, FeigelP, MetchB et al. Quality of Life end points in cancer clinical trials: Review and recommendations.J Natl Cancer Inst 1989;7: 485–495.
SchagCC, HeinrichRL, GanzPA. Cancer Inventory of Problem Situations: An instrument for assessing cancer patients' rehabilitation needs.J Psychosocial Oncol 1983;1: 11–24.
HeinrichRL, SchagCC, GanzPA. Living with cancer: The Cancer Inventory of Problem Situations.J Clin Psych 1984;40: 972–980.
SchagCC, HeinrichRL. The impact of cancer on daily living: a comparison with cardiac patients and healthy controls.Rehab Psych 1986;31: 157–167.
GanzPA, RofessartJ, PolinskyML, SchagCC, HeinrichRL. A comprehensive approach to cancer patients' needs assessment: The Cancer Inventory of Problem Situations (CIPS) and a companion interview.J Psychosocial Oncol 1986;4: 27–42.
SchagCAC, HeinrichRL.CAncerRehabilitationEvaluationSystem (CARES): Manual. First Edition. Los Angeles: CARES Consultants, 1989.
Ganz PA, Schag CC, Heinrich RL. Cancer Rehabilitation. In: Haskell CM, ed.Cancer Treatment, WB Saunders, 1990.
SchagCAC, HeinrichRL, AadlandRL, GanzPA. Assessing problems of cancer patients: Psychometric properties of the Cancer Inventory of Problem Situations.Health Psych 1990;9: 83–102.
SchagCAC, HeinrichRL. Developing a comprehensive tool: TheCAncerRehabilitationEvaluationSystem.Oncology 1990;4: 135–138.
SchagCAC, GanzPA, HeinrichRL.CAncerRehabilitationEvaluationSystem-Short-Form (CARES-SF): A cancer specific rehabilitation and quality of life instrument.Cancer 1991;68: 1406–1413.
GanzPA, SchagCAC, LeeJJ, SimM-S. The CARES: A generic measure of health-related quality of life for cancer patients.Quality Life Res 1992;1: 19–29.
SchagCAC, GanzPA, KahnB, PetersenL. HOPES: A quality of life tool for HIV (Abstract).Proceedings Annual Meeting of the American Society of Clinical Oncology. 1992;11: 46.
KarnofskyDA, BurchenalJH. The clinical evaluation of chemotherapeutic agents in cancer. In: McCleodCM, ed.Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949; 191–205.
SchagCC, HeinrichRL, GanzPA. Karnofsky performance status revisited: Reliability, validity, and guidelines.J Clin Oncol 1984;2: 187–193.
TarlovAR, WareJEJr, GreenfieldS, NelsonEC, PerrinE, ZubkoffM. The Medical Outcomes Study: an application of methods for monitoring the results of medical care.JAMA 1989;262: 925–930.
WareJE, SherbourneCD, DaviesAR. Developing and testing the MOS 20-item Short-Form health survey: a general population application. In: StewartAL, WareJE, eds.Measuring Functioning and Well-being: The Medical Outcome Study Approach. Durhan, NC; Duke University Press, 1992.
StewartAL, HaysRD, WareJE. The MOS short-form general health survey: reliability and validity in a patient population.Med Care 1988;26: 724–735.
WuAW, RubinHR, MathewsWC et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection.Med Care 1991;29: 786–798.
McnairDM, LorrM, DroppelmanLF.Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service, 1981.
CassilethBR, LuskEJ, MillerDS, et al. Psychosocial correlates of survival in advanced malignant disease.New Engl J Med 1985;312: 1551–1555.
GorskyRD, CallowayDH. Activity pattern changes with decreases in food energy intake.Human Biology 1983;55: 557–586.
BloomJR, GorskyRD, FobairP, et al. Physical performance at work and at leisure: validation of a measure of biological energy in survivors of Hodgkin's disease.J Psychosocial Oncology 1990;8: 49–63.
RaheRH. Epidemiological studies of life change and illness.Int J Psychiatry in Med 1975;6: 133–146.
RogentineGN, vanKammenDP, FoxBH, et al. Psychological factors in the prognosis of malignant melanoma: a prospective study.Psychosomatic Med 1979;41: 647–655.
GotayCC. Why me: Attributions and adjustment by cancer patients and their mates at two stages in the disease process.Soc Sci Med 1985;20: 825–831.
GoughIR, FurnivalCM, SchilderL, et al. Assessment of the quality of life of patients with advanced cancer.Eur J Cancer Clin Oncol 1983;19: 1161–1165.
CronbachLJ. Coefficient alpha and the internal structure of tests.Psychometrika 1951;16: 297.
NunnallyJC.Psychometric Theory, 2nd ed. New York: McGraw-Hill, 1978.
GorsuchRL. Higher-order factors. In: GorsuchRL, ed.Factor Analysis. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc. 1983; 239–256.
SAS Institute Inc.SAS/STAT Users Guide, Version 6 4th Edition, Vol. 1. Cary N.C.: SAS Institute Inc., 1989.
Ganz PA, Schag CAC, Kahn B, Petersen L, Hirji K. Describing the quality of life impact of HIV infection: Findings from studies with theHIVOverview ofProblems-EvaluationSystem (HOPES). Submitted for Publication.
HaysRD, ShapiroMF. An overview of generic health-related quality of life measures for HIV research.Quality Life Res 1992;1: 91–97.
WachtelT, PietteJ, MorV, SteinM, FleishmanJ, CarpenterC. Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument.Ann Int Med 1992;116: 129–137.
KaplanRM, AndersonJP, WuAW, MathewsWC, KozinF, OrensteinD. The quality of Well-being Scale.Med Care 1989;27: S27–S43.
KaplanRM, BushJW. Health-related quality of life measurement for evaluation research and policy analysis.Health Psychol 1982;1: 61–80.
LandgrafJM, NelsonEC, HaysRD, et al. Assessing function: does it really make a difference: a preliminary evaluation of the acceptability and utility of the COOP function charts. In: LipkinM, ed.Functional Status Measurement in Primary Care. New York: Springer-Verlag, 1990: 150–165.
Author information
Authors and Affiliations
Additional information
This paper is dedicated to the memory of Jimmy Stophel who died of AIDS and whose sense of humour improved the quality of many people's lives.
This research was supported in part by the UCLA AIDS Clinical Research Center and CARES Consultants. To obtain information about the HOPES, please contact C. A. Coscarelli Schag, CARES Consultants, 2210 Wilshire Blvd., Suite 359, Santa Monica, CA 90403, USA.
Rights and permissions
About this article
Cite this article
Schag, C.A.C., Ganz, P.A., Kahn, B. et al. Assessing the needs and quality of life of patients with HIV infection: development of theHIVOverview ofProblems-EvaluationSystem (HOPES). Qual Life Res 1, 397–413 (1992). https://doi.org/10.1007/BF00704434
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00704434